Suzhou Fushilai Pharmaceutical (301258.SZ) obtained the registration certificate for L-cysteine tablets.
Fuji Lei (301258.SZ) announcement, the company recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for thioparcacid tablets. Indication of thioparcacid tablets: Used for sensory abnormalities caused by diabetic peripheral neuropathy.
Suzhou Fushilai Pharmaceutical (301258.SZ) announced that the company recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for Lipoic Acid Tablets. The indications for Lipoic Acid Tablets are: used for sensory abnormalities caused by peripheral neuropathy in diabetes.
Related Articles

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


